Clinical Trials for Ulcerative Colitis

Find clinical trials for ulcerative colitis. Discover research opportunities and treatment options in your area.

216 Active Trials Found

Showing 216 trials on this page

Page 3 of 11

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06254950

This clinical trial is studying a new medication called TAK-279 to see if it can help reduce inflammation in the bowels of people with moderately to severely active ulcerative colitis (UC). The mai...

Recruiting

Phase: PHASE2 Type: interventional Locations: Heidelberg, Victoria, Australia, Tilburg, , Netherlands +207 more

Treatment of UC With Novel Therapeutics

NCT ID: NCT06420375

This clinical trial is studying a new drug called BRS201 to see if it can help patients with mild ulcerative colitis, a condition that causes inflammation in the intestines. The study will last for...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chestnut Hill, Massachusetts, United States

Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis

NCT ID: NCT06764706

This clinical trial is studying the effects of a medication called risankizumab on adults with moderate to severe ulcerative colitis (UC), a condition that causes inflammation and bleeding in the c...

Recruiting

Type: observational Locations: Koblenz, Rheinland Pfalz, Germany, Altenholz, Schleswig Holstein, Germany +36 more

Personalized Anti-Inflammatory Fibres in Ulcerative Colitis

NCT ID: NCT06515210

This clinical trial is looking at how two different types of dietary fiber supplements—acacia gum (AG) and microcrystalline cellulose (MCC)—can help reduce inflammation in patients with ulcerative ...

Recruiting

Phase: NA Type: interventional Locations: Edmonton, Alberta, Canada

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

NCT ID: NCT06964113

This clinical trial is studying the effectiveness of a medication called filgotinib in helping people with moderately to severely active ulcerative colitis achieve clinical remission, which means t...

Recruiting

Phase: PHASE4 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +12 more

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

NCT ID: NCT03251118

The TARGET-IBD study is a 5-year research project looking at patients with Inflammatory Bowel Disease (IBD), which includes conditions like Crohn's disease, ulcerative colitis, and indeterminate co...

Recruiting

Type: observational Locations: Minneapolis, Minnesota, United States, Houston, Texas, United States +35 more

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

NCT ID: NCT06764615

This clinical trial is studying a medication called TAK-279 for adults with Ulcerative Colitis (UC) and Crohn's Disease (CD), which are serious conditions that cause inflammation in the intestines....

Recruiting

Phase: PHASE2 Type: interventional Locations: Tyler, Texas, United States

Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis

NCT ID: NCT05892159

This clinical trial is looking at a new way to help people with ulcerative colitis, a condition that causes inflammation in the intestines. The researchers want to see if a technique called Heart R...

Not yet recruiting

Phase: NA Type: interventional

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

NCT ID: NCT06109441

This clinical trial is studying a new treatment called ALTB-268 for people with moderately to severely active ulcerative colitis (UC) who have not responded well to previous biologic therapies. The...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Milwaukee, Wisconsin, United States +32 more

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

NCT ID: NCT06838845

This clinical trial is looking at how effective a medication called upadacitinib is for treating moderate to severe ulcerative colitis (UC) in Chinese adults. UC is a long-lasting condition that ca...

Recruiting

Type: observational Locations: Zhengzhou, Henan, China, Guangzhou, Guangdong, China +1 more

Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.

NCT ID: NCT05895981

This clinical trial is exploring a new treatment option for patients with ulcerative colitis, a type of inflammatory bowel disease that causes lasting inflammation in the digestive tract. The trial...

Recruiting

Phase: NA Type: interventional Locations: Xi'an, Shaanxi, China

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

NCT ID: NCT06231264

This clinical trial is looking at a treatment called transcutaneous electrical acustimulation for people with mild to moderate ulcerative colitis, a condition that causes inflammation in the intest...

Recruiting

Phase: NA Type: interventional Locations: Xi'an, Shaanxi, China, Xi'an, Shaanxi, China +2 more

Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis

NCT ID: NCT04743518

This clinical trial is studying how certain medications for ulcerative colitis (UC) affect the risk of heart problems in patients. Specifically, it looks at three types of treatments: anti-TNF medi...

Recruiting

Phase: PHASE4 Type: interventional Locations: Amiens, , France

Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study

NCT ID: NCT06998797

This clinical trial is studying the effectiveness of a treatment called subcutaneous Infliximab for patients with acute severe ulcerative colitis, a serious form of inflammatory bowel disease. Typi...

Not yet recruiting

Type: observational

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

NCT ID: NCT06956703

The NAZA trial is a research study that aims to understand the differences in inflammation markers between people with inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis,...

Recruiting

Type: observational Locations: Nottingham, , United Kingdom

Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

NCT ID: NCT06998316

The QUESAM study is a clinical trial aimed at helping doctors identify spondylo-arthritis in patients who have inflammatory bowel disease, such as Crohn's disease or ulcerative colitis. Researchers...

Not yet recruiting

Type: observational Locations: Grenoble, , France

Immunological Characteristics of Preclinical IBD

NCT ID: NCT05698745

This clinical trial is studying the immune system characteristics of patients with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. The goal ...

Recruiting

Type: observational Locations: Madrid, , Spain, Zaragoza, , Spain +25 more

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT ID: NCT04738942

This clinical trial is studying a medication called vedolizumab, which is given through an IV (intravenous) drip, to see if it helps improve symptoms in Japanese patients with moderate to severe ul...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shimotsuke, Tochigi, Japan, Osaka, , Japan +21 more

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

NCT ID: NCT06315179

The Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) trial is studying how gut inflammation affects children with inflammatory bowel diseases, such as Crohn...

Recruiting

Type: observational Locations: Seattle, Washington, United States

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06453317

This clinical trial is designed to investigate whether a combination of two medications, infliximab and ustekinumab, is more effective than using each medication on its own for adults with moderate...

Recruiting

Phase: PHASE2 Type: interventional Locations: łódź, , Poland

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions